Home › Grants › United States › Studies Addressing Rare Neurodegenerative Diseases including ALS

Studies Addressing Rare Neurodegenerative Diseases including ALS

The purpose of this funding opportunity announcement (FOA) is to support studies that advance medical product development of interventions intended to prevent, diagnose, mitigate, treat, or cure ALS and other rare neurodegenerative diseases in adults and children.

Grant (non-repayable) Opening soon

Funder

Food and Drug Administration
Funder profile and all of its programs

Amount

Award amounts are not published in the listing; see the official page.

Where

United States (federal)

Eligibility

Open to businesses, self-employed people, nonprofits, individuals, colleges, universities, schools or research institutions and state, provincial, local or tribal governments. No cost sharing is required. Forecast: the funder has announced this opportunity but not yet opened it; dates are estimates.

Sectors

Agriculture and agri-food, Health and life sciences, Nonprofits and charities

Deadline

Varies: check the official page for current dates

Source

Grants.gov XML extract (FOR-FD-25-006)

Last checked

2 November 2026

Funder contacts

Public organizational contacts on file Unlock full profile / Sign up

Official page ↗

From official open data: listed in the official Grants.gov extract on 2026-11-02. The summary is from the official listing; the eligibility line is our plain-language reading of its eligibility codes. Confirm details on the official page.

Related grant lists

Agriculture and agri-food Health and life sciences Nonprofits and charities Governments and public bodies Individuals Schools, colleges and research institutions United States United States (national) Federal agency

Information only. GrantSift is not affiliated with any funder. A match means a program is likely eligible or worth checking, not that you will be funded. Always confirm details on the official page. Applying through official portals is free.